Mixed connective tissue disease: Overlap syndromes

Bailliere's Best Practice and Research in Clinical Rheumatology

Volumn 14, Issue 1, 2000, Pages 111-124

  Maddison, Peter J ^a,b  

^a YSBYTY GWYNEDD   (United Kingdom)

^b BANGOR UNIVERSITY   (United Kingdom)

Author keywords

Anti UIRNP; Mixed connective tissue disease; Overlap syndrome

Indexed keywords

AUTOANTIBODY;

CLINICAL FEATURE; DISEASE CLASSIFICATION; HUMAN; IMMUNOGENETICS; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; REVIEW; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 0034120073     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.1999.0080     Document Type: Article

References (58)

1. Tan E M, Cohen A S, Fries J F. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism. 25:1982;1271-1277.
2. Arthritis and Rheumatism. 23:1980;581-590.
3. Venables P JW. Undifferentiated connective tissue diseases: mixed or muddled? Lupus. 7:1998;73-74.
4. Harley J B, Gaither K K. Autoantibodies. Rheumatic Disease Clinics of North America. 14:1988;43-55.
5. Gharavi A E, Chu J-L, Elkon K B. Autoantibodies to intracellular proteins in human systemic lupus erythematosus are not due to random polyclonal B cell activation. Arthritis and Rheumatism. 31:1988;1337-1345.
6. Marguerie C, Bunn C C, Beynon H LC. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl tRNA synthetases. Quarterly Journal of Medicine. 77:1990;1019-1038.
7. Marguerie C, Bunn C C, Copier J. The clinical and immunogenetic features of patients with antibodies to the nucleolar antigen PM-Scl. Medicine. 71:1992;327-336.
8. Lazaro M A, Maldonado J A, Cocco M D. Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity? Medicine. 68:1989;58-65.
9. Sharp G C, Irving W, Tan E, Gould G, Holman H. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). American Journal of Medicine. 52:1972;148-159.
10. Nimelstein S H, Brody S, McShane D, Holman M R. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine. 59:1980;239-248.
11. Sharp G C. Mixed connective tissue disease. Bulletin of the Rheumatic Diseases. 25:1979;43-45.
12. Smolen J S, Steiner G. Mixed connective tissue disease. To be or not to be? Arthritis and Rheumatism. 41:1998;768-777.
13. Sharp G C, Anderson P C. Current concepts in the classification of connective tissue disease. Overlap syndromes and mixed connective tissue disease (MCTD). Journal of the American Acadamy of Dermatology. 2:1980;269-274.
14. Piirainen H I. Patients with arthritis and anti-U1RNP antibodies: a 10 year follow-up. British Journal of Rheumatology. 29:1990;345-352.
15. Farhey Y, Hess E V. Mixed connective tissue disease. Arthritis Care Research. 10:1997;333-338.
16. Singsen B H, Swanson V L, Bernstein B H. A histological evaluation of mixed connective tissue disease in childhood. American Journal of Medicine. 68:1980;710-717.
17. Granier F, Vayssairat M, Priollet P, Housset E. Nailfold capillary microscopy in mixed connective tissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus. Arthritis and Rheumatism. 29:1986;189-195.
18. Potter J S, Gabor G T, Porter J M, Bennett R M. Angiographic findings in mixed connective tissue disease. Arthritis and Rheumatism. 28:1985;768-774.
19. Ozawa T, Ninomiya Y, Honma T. Increased serum angiotensin I-converting enzyme activity in patients with mixed connective tissue disease and pulmonary hypertension. Scandinavian Journal of Rheumatology. 24:1995;38-43.
20. Watanabe H, Kaise S, Takeda I. Anti endothelial cell antibodies in the sera of patients with mixed connective tissue disease - the clinical significance. Fukushima Journal of Medical Sciences. 43:1997;13-28.
21. Kasukawa R, Nishimaki T, Takagi T. Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study. Clinical Rheumatology. 9:1995;56-62.
22. Burdt M A, Hoffman R W, Deutscher S L. Long-term outcome in mixed connective tissue disease. Longitudinal clinical and serologic findings. Arthritis and Rheumatism. 42:1999;899-909.
23. Ramos-Niembro R, Alarcón-Segovia D, Hernandes Ortiz J. Articular manifestations of mixed connective tissue disease. Arthritis and Rheumatism. 22:1979;43-51.
24. Reilly P A, Evison G, McHugh N J, Maddison P J. Arthropathy of hands and feet in systemic lupus erythematosus. Journal of Rheumatology. 17:1990;777-784.
25. Alarcón-Segovia D, Uribe-Uribe O. Mutilans-like arthropathy in mixed connective tissue disease. Arthritis and Rheumatism. 22:1979;1013-1019.
26. Stuart R A, Maddison P J. Altantoaxial subluxation in a patient with mixed connective tissue disease. Journal of Rheumatology. 18:1991;1617-1620.
27. Piirainen H I. Patients with arthritis and anti-U1RNP antibodies: a 10-year follow-up. British Journal of Rheumatology. 29:1990;345-348.
28. Black C M, Maddison P J, Welsh K I. HLA and immunoglobulin allotypes in mixed connective tissue disease. Arthritis and Rheumatism. 31:1988;131-135.
29. Oxenhandler R, Hart M, Corman L, Sharp G, Adelstein E. Pathology of skeletal muscle in MCTD. Arthritis and Rheumatism. 20:1977;985-988.
30. Norman D A, Fleischmann R M. Gastrointestinal systemic sclerosis in serologic mixed connective tissue disease. Arthritis and Rheumatism. 21:1978;811-819.
31. Leung W-H, Wong K-L, Lau C-P. Echocardiographic identification of mitral valvular abnormalities in patients with mixed connective tissue disease. Journal of Rheumatology. 17:1990;485-488.
32. Prakash U B. Respiratory complications in mixed connective tissue disease. Clinics in Chest Medicine. 19:1998;733-746.
33. Koboyashi S, Magase M, Kimura M. Renal involvement in mixed connective tissue disease. American Journal of Nephrology. 5:1985;282-287.
34. Van Venrooij W J, Sillekens P TG. Small nuclear RNA-associated proteins: Autoantigens in connective tissue disease. Clinical and Experimental Immunology. 7:1989;635-645.
35. Habets W J, de Rooij D J, Salven M H, van Venrooij W R. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Clinical and Experimental Immunology. 54:1983;267-276.
36. Lundberg I, Hedfors E. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients. Journal of Rheumatology. 18:1991;1511-1519.
37. Reichlin M, van Venrooij W J. Autoantibodies to the URNP particles: relationship to clinical diagnosis and nephritis. Clinical and Experimental Immunology. 83:1991;286-290.
38. Barakat S, Briand J P, Abuaf N, van Regenmortel M HV, Muller S. Mapping of epitopes on U1snRNP polypeptide A with synthetic peptides and autoimmune sera. Clinical and Experimental Immunology. 86:1991;71-78.
39. Hassfield W, Steiner G, Studnicka-Benke A. Autoimmune response to the spliceosome: an immunologic link between rheumatoid arthritis, mixed connective tissue disease and systemic lupus erythematosus. Arthritis and Rheumatism. 38:1995;777-785.
40. Skriner K, Sommergruber W H, Tremmel V. Anti A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex: differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus and mixed connective tissue disease. Journal of Clinical Investigation. 100:1997;127-135.
41. Hoffman R W, Sharp G C, Deutscher S L. Analysis of anti-U1RNA antibodies in patients with connective tissue disease. Arthritis and Rheumatism. 38:1995;1837-1844.
42. Hoffman R W, Rettenmaier L J, Takeda Y. Human autoantibodies against the 70kD polypeptide of U1 small nuclear RNP are associated with HLA-DR4 among connective tissue disease patients. Arthritis and Rheumatism. 33:1990;666-673.
43. Bunn C C, Denton C P, Shi-Wen X, Knight C, Black C M. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. British Journal of Rheumatology. 37:1998;15-20.
44. Hoffman R W, Sharp G C. Is anti-U1-RNP autoantibody positive connective tissue disease genetically distinct? Journal of Rheumatology. 22:1995;586-587.
45. Kaneoka H, Hsu K C, Takeda Y, Sharp G C, Hoffman R. Molecular genetic analysis of HLA DR and HLA DQ genes among anti U170 kD autoantibody positive connective tissue disease patients. Arthritis and Rheumatism. 35:1992;83-94.
46. Black C M, Maddison P J, Welsh K I. HLA and immunoglobulin allotypes in mixed connective tissue disease. Arthritis and Rheumatism. 31:1988;131-135.
47. Bakri Hassan A, Ronnelid J, Gunnarsson I. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease. Journal of Autoimmunity. 11:1998;503-508.
48. Jacob C O, Fronek Z, Lewis G D. Heritable major histocompatibility complex class II-associated differences in relevance to genetic predisposition to systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the USA. 87:1990;1233-1237.
49. Sharp G C. Diagnostic criteria for classification of MCTD. Kasukawa R, Sharp G C. Mixed Connective Tissue Disease and Anti-nuclear Antibodies. 1987;23-32 Excerpta Medica, Amsterdam.
50. Alarcón-Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. Kasukawa R, Sharp G C. Mixed Connective Tissue Disease and Anti-nuclear Antibodies. 1987;33-40 Excerpta Medica, Amsterdam.
51. Kasukawa R, Tojo T, Miyawaki S. Preliminary diagnostic criteria for classification of mixed connective tissue disease. Kasukawa R, Sharp G C. Mixed Connective Tissue Disease and Anti-nuclear Antibodies. 1987;41-47 Excerpta Medica, Amsterdam.
52. Kahn M F, Appelboom T. Syndrome de Sharp. Kahn M F, Peltier A P, Meyer O, Piette J C. Les Maladies Systemiques. 1991;545-552 Flammarion, Paris.
53. Amigues J-M, Cantagrel A, Abbal M, Mazieres B. Comparative study of 4 diagnostic criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Journal of Rheumatology. 23:1996;2055-2062.
54. Kahn M F. Mixed connective tissue disease. Lupus. 4:1995;258.
55. Gendi N S, Welsh K I, van Venrooij W J. HLA type as a predictor of mixed connective tissue disease differentiation. Ten-year clinical and immunogenetic follow-up of 46 patients. Arthritis and Rheumatism. 38:1995;259-266.
56. Alarcón-Segovia D, Ruiz-Arguelles A, Fishbein E. Antibody to nuclear ribonucleoprotein penetrates live human cells through Fc receptors. Nature, London. 271:1978;69-74.
57. Alarcón-Segovia D, Llorente L, Ruiz-Arguelles A. The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dysregulation and/or cell damage. Journal of Autoimmunity. 9:1996;295-300.
58. Holyst M M, Hill D L, Hoch S O, Hoffman R W. Analysis of human T cell and B cell responses against U small nuclear ribonucleoprotein 70-kd, B, and D polypeptides among patients with systemic lupus erythematosus and mixed connective tissue disease. Arthritis and Rheumatism. 40:1997;1493-1503.